EWM
RPRX icon

Empirical Wealth Management’s Royalty Pharma RPRX Stock Holding History

Empirical Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Buy
+4,625
New +$241K ﹤0.01% 916
2026
Q1 		– Sell
-6,424
Closed -$248K – 1033
2025
Q4 		$248K Sell
6,424
-456
-7% -$17.4K ﹤0.01% 772
2025
Q3 		$243K Buy
+6,880
New +$249K ﹤0.01% 692

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
TIP
Torray Investment Partners Bethesda, Maryland $741M AUM 26.16% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Empirical Wealth Management's RPRX Position: Q2 2026 in Review

Empirical Wealth Management opened a new position in Royalty Pharma (RPRX) in Q2 2026: 4,625 shares worth $259K. The stake represents ﹤0.01% of the portfolio and ranks #916 among its holdings. This is a return to the name: Empirical Wealth Management previously reported a position in RPRX as recently as Q4 2025.

Empirical Wealth Management first reported a position in RPRX in Q3 2025 and has held it in 3 quarters since. 168 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Empirical Wealth Management held 4,625 shares of Royalty Pharma worth $259K as of Q2 2026.
  • Royalty Pharma was a new Empirical Wealth Management position in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #916 holding.
  • Empirical Wealth Management first reported a position in Royalty Pharma in Q3 2025 and has held it in 3 quarters since.
  • 168 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.